SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Rubicon Organics Inc. ROMJF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Rubicon Organics Inc. (ROMJF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.38. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $59M, +18.8%/yr average growth. Net income is $1M, growing at +52%/yr. Net profit margin is 1.8% (thin). Gross margin is -11.4% (-50.3 pp trend).

Balance sheet: total debt is $12M against $44M equity (Debt-to-Equity (D/E) ratio 0.28, conservative). Current ratio is 2.94 (strong liquidity). Debt-to-assets is 18.6%. Total assets: $67M.

SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 90/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

ROMJF SharesGrow Score Overview

57/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 75/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 0/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ROMJF

ROMJF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ROMJF: +18.8%/yr revenue is, +52%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ROMJF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ROMJF: Debt-to-Equity (D/E) ratio 0.28 (conservative), Current ratio is 2.94 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

No analyst coverage available for this stock.

ROMJF: Net profit margin is 1.8%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.28-0.542

Volume22.74K

Avg Volume (30D)19.07K

Market Cap$25.82M

Beta (1Y)0.37

Share Statistics

EPS (TTM)0.02

Shares Outstanding$65.91M

IPO Date2018-10-24

Employees208

CEOMargaret Ruth Brodie

Financial Highlights & Ratios

Revenue (TTM)$59.4M

Gross Profit$-6.79M

EBITDA$-11.96M

Net Income$1.05M

Operating Income$-15.32M

Total Cash$3.99M

Total Debt$12.41M

Net Debt$8.43M

Total Assets$66.84M

Price / Earnings (P/E)23.9

Price / Sales (P/S)0.43

Analyst Forecast

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINCA78112W1005

Price Chart

ROMJF

Rubicon Organics Inc. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

0.28 52WK RANGE 0.54

People Also View

RAMM Pharma Corp.

City View Green Holdings Inc.

Pure Harvest Corporate Group, Inc.

Speakeasy Cannabis Club Ltd.

RavenQuest BioMed Inc.

Craftport Cannabis Corp.

BC Craft Supply Co. Ltd.

Eli Lilly and Company

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message